Methoxypiperamide

Methoxypiperamide

Methoxypiperamide
Systematic (IUPAC) name
(4-Methoxyphenyl)(4-methylpiperazin-1-yl)methanone
Clinical data
Legal status
  • Illegal in Hungary
Chemical data
Formula C13H18N2O2
Molecular mass 234.30 g·mol−1

Methoxypiperamide (also known as MeOP and MEXP) is a psychoactive drug of the piperazine class that has been sold online as a designer drug.[1][2] It is the 4-methoxy-α-keto analog of methylbenzylpiperazine.

Very little data exists about the pharmacology and toxicity of methoxypiperamide; however, the US state of Vermont classifies it as a hallucinogen.

Legal status

Methoxypiperamide is a controlled substance in Vermont as of January 2016,[3] and also in Hungary.[4]

See also

References

  1. ^ Power JD, Scott KR, Gardner EA, Curran McAteer BM, O'Brien JE, Brehon M, Talbot B, Kavanagh PV (January 2014). "The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine". Drug Testing and Analysis 6 (7-8): 668–75.  
  2. ^ Markus R. Meyer, Anna Holderbaum, Pierce Kavanagh, Hans H. Maurer (October 2015). "Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP)". Journal of Mass Spectrometry 50 (10): 1163–1174.  
  3. ^ "Regulated Drugs Rule" (PDF). Vermont Department of Health. Retrieved 14 October 2015. 
  4. ^ A Magyarországon megjelent, a Kábítószer és Kábítószer-függőség Európai Megfigyelő Központjának Korai Jelzőrendszerébe (EMCDDA EWS) 2005 óta bejelentett ellenőrzött anyagok büntetőjogi vonatkozású besorolása